| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.092 | 0.05 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | 0.34 | 0.06 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.091 | 0.06 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.062 | 0.06 |